You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. HUCBC modulation of Alzheimer's-like pathology and behavioral changes

    SBC: SANERON CCEL THERAPEUTICS, INC.            Topic: NIA

    DESCRIPTION (provided by applicant): In the past years, we have shown that human umbilical cord blood cells (HUCBC, U-CORD- CELL ) provide cognitive recovery in animal models of neurodegenerative disease. Infusion of HUCBC resulted in reduced infarct volume as well as in rescue of behavioral benefits in an animal model of stroke. We further showed that HUCBC infusion proved to be beneficial in ani ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  2. A Home Exercise Program (DVD) for Women with Infants and Young Children

    SBC: KLEIN BUENDEL, INC.            Topic: NIDA

    DESCRIPTION (provided by applicant): Becoming a mother is a significant transition in a woman's life. This transition can precipitate major changes in health behaviors, like physical activity. Once a woman has a child she is much less likely to participate in regular, moderate to vigorous physical activity compared to women without children. Thus, new mothers are at risk for future weight gain and ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  3. Acute-infarct selective cardiac MRI contrast agent

    SBC: ELGAVISH PARAMAGNETICS, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant The overall goal of this project is to demonstrate the ability of our acute myocardial infarct selective paramagnetic contrast agent Gadolinium ABE DTTA to differentiate between acute and chronic infarcts in a reliable manner using contrast enhanced magnetic resonance imaging ceMRI In our Phase I data we have shown that Gd ABE DTTA exclusively highlight ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  4. Development of Low-Cost Augmented Reality Head Mounted Display

    SBC: SA PHOTONICS, LLC            Topic: N09T031

    SA Photonics, in conjunction with our teammates at the University of Arizona, have developed LARS, the low-cost augmented reality system. This system is a see-through HMD used for training and simulation. LARS was designed using an innovative freeform prism combiner which is small, lightweight and has very little obscuration of the outside world. We have partnered with Rockwell Collins Optronics ( ...

    STTR Phase II 2010 Department of DefenseNavy
  5. Visible Electro-Optical (EO) System and LIDAR Fusion for Low Cost Perception by Autonomous Ground Vehicles

    SBC: TOYON RESEARCH CORPORATION            Topic: N11AT020

    The Toyon-MST team proposes to perform research and development of a system which fuses multi-spectral EO and 3D data collected with a low-cost LIDAR to enable improved perception for unmanned ground vehicles (UGVs). The scope of the proposed work includes development of algorithms and software, and development, implementation, integration, testing, and delivery of a prototype, to perform EO-LIDAR ...

    STTR Phase II 2013 Department of DefenseNavy
  6. Planar, High Frequency, Power Conversion Device Technology

    SBC: TRANSPHORM, INC.            Topic: N09T023

    Transphorm proposes to demonstrate a normally off fast high voltage Gallium Nitride power switch solution. The switch would block to 1200V, have a threshold voltage greater than 5 V, and the phase 2 switch will target an on resistance less than 15 ohm-mm and current more than 1 Amp. To accomplish these targets, Transphorm will combine the design requirements of realizing a high (and positive) thre ...

    STTR Phase II 2010 Department of DefenseNavy
  7. Electro Optic Avionic Advanced Guidance, Navigation and Control (GNC) Algorithm Development to Enhance the Lethality of Interceptors Against Maneuveri

    SBC: POLARIS SENSOR TECHNOLOGIES INC            Topic: MDA08T003

    This Phase II effort will further develop a technique to improve current seeker discrimination and tracking capabilities using a unique particle filter algorithm (PFA) approach. The advancement represents a significant upgrade to current and future seekers facing advanced threats in stressing environments. Quantifiable improvements over many facets of the current approach have been realized during ...

    STTR Phase II 2010 Department of DefenseMissile Defense Agency
  8. Exact modeling of targets in littoral environments

    SBC: HEAT, LIGHT, AND SOUND RESEARCH, INC.            Topic: N09T026

    The US Navy needs the capability to model acoustic propagation in complex ocean environments containing natural or man-made objects. Such accurate modeling requires the solution of the wave equation in the ocean containing scatterers. In the absence of the scatterer, the oceanic waveguide can be assumed to be axially symmetric. This allows certain types of physically valid approximations to be mad ...

    STTR Phase II 2010 Department of DefenseNavy
  9. Optogenetic Multiparametric Assay for HT Cardiotoxicity Testing

    SBC: VALA SCIENCES, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): Monitoring physiology of individual cardiomyocytes in high throughput has not been reported. The inability to perform high throughput physiological measurements limits many basic and applied studies, including the use of stem cell derived cardiomycoytes in cardiotoxicity testing. Current automated cardiotoxicity tests have poor predictive value because they use ...

    STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Multipurpose reversible terminators

    SBC: FIREBIRD BIOMOLECULAR SCIENCES LLC            Topic: NHGRI

    DESCRIPTION (provided by applicant): This Phase 2 STTR application will allow the Foundation for Applied Molecular Evolution (FfAME) to complete its transfer of technology to Firebird Biomolecular Sciences LLC, allowing Firebird to commercialize nucleoside triphosphates where the 3'-OH groups are blocked by a 3'-ONH2 group. Triphosphates having this modification are accepted by DNA polymerases and ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government